How to legally get Strattera online in New York

In the evolving landscape of telehealth, many patients with ADHD wonder if they can access medications like Strattera without in-person doctor visits. The good news is that non-stimulant ADHD medications like Strattera are generally accessible through telehealth services across the United States. This comprehensive guide explains the current telehealth regulations for Strattera prescriptions, state-by-state rules, and what you need to know before seeking treatment online.

What is Strattera and Why Is It Different?

Strattera (atomoxetine) is an FDA-approved non-stimulant medication for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults. Unlike stimulant ADHD medications like Adderall or Ritalin, Strattera is not a controlled substance. This key difference makes it significantly easier to prescribe through telehealth platforms across all states.

The medication works by increasing norepinephrine levels in the brain, which helps improve attention and decrease impulsivity and hyperactivity. Because Strattera is not habit-forming and has no potential for abuse, it isn’t subject to the strict DEA regulations that govern stimulant medications.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Can I Get Strattera Through Telehealth?

Yes, you can get Strattera (atomoxetine) prescribed through telehealth in all 50 states. Since it’s not a controlled substance, Strattera isn’t subject to the DEA’s in-person examination requirements that sometimes apply to stimulant ADHD medications.

Here’s what makes telehealth prescribing of Strattera possible:

• No federal in-person requirement: The Ryan Haight Act, which sometimes requires in-person visits before prescribing controlled substances, doesn’t apply to non-stimulant medications like Strattera
• State-friendly telehealth laws: Most states have enacted laws that explicitly permit telehealth for non-controlled medications
• Standard of care: As long as the telehealth provider follows the standard of care for diagnosing and treating ADHD, they can legally prescribe Strattera

A licensed provider can evaluate you over video, confirm an ADHD diagnosis, and e-prescribe Strattera if appropriate for your condition.

Key Benefits of Telehealth for ADHD Non-Stimulant Treatment

Getting Strattera through telehealth offers several advantages:

1. Convenience and accessibility: Receive care from home, eliminating travel time and reducing barriers to treatment
2. Consistent refills: Strattera can often be prescribed for 90-day supplies, unlike stimulants which typically require monthly prescriptions
3. Fewer regulatory hurdles: No prescription monitoring program (PMP) checks required in most states
4. Expanded provider options: In states with provider shortages, telehealth connects patients to qualified clinicians who might not be available locally
5. Flexible follow-up: Remote monitoring is suitable for medication like Strattera, which requires periodic blood pressure checks but not the intensive monitoring of stimulants

At Klarity Health, we’ve found that telehealth ADHD care allows patients to maintain consistent treatment with fewer logistical barriers, especially for those who might otherwise struggle to access in-person psychiatric care.

Federal Regulations: Current Status

As of December 2025, federal telehealth regulations make a clear distinction between controlled substances (stimulants) and non-controlled medications like Strattera:

For Strattera (Non-Controlled):

• No federal restriction on telehealth prescribing
• No requirement for prior in-person examination
• No special DEA registration needed for prescribers
• Standard e-prescribing rules apply (no special requirements)

For Stimulant ADHD Medications (For Comparison):

• Currently under temporary DEA flexibilities through December 31, 2025
• Without these flexibilities, stimulants would require an in-person exam under the Ryan Haight Act
• The DEA is reviewing a potential fourth extension or permanent solution for 2026

The key takeaway: Even if DEA rules change for controlled substances after December 2025, Strattera prescribing via telehealth will remain unaffected since it’s not subject to these regulations.

State-by-State Telehealth Rules for Strattera

While federal law permits telehealth prescribing of Strattera nationwide, state regulations add some variation. Here’s what you need to know about key states:

California

• Telehealth for Strattera: Fully permitted
• In-person requirement: None for non-controlled medications
• Provider types: Both physicians and nurse practitioners can prescribe

California has embraced telehealth, with its 2023 telehealth modernization law making it easier to establish provider-patient relationships virtually. Strattera prescriptions face no special restrictions.

New York

• Telehealth for Strattera: Allowed with no restrictions
• In-person requirement: None for non-controlled medications
• Note: NY’s 2025 rule requiring in-person exams before telehealth prescribing of controlled substances does NOT apply to Strattera

Florida

• Telehealth for Strattera: Fully permitted
• In-person requirement: None
• Provider types: NPs must have physician collaboration
• Special considerations: Florida requires video visits (no phone-only) for establishing care

Florida law specifically allows telehealth prescribing of non-controlled substances without restrictions. The state’s rules around controlled substances are stricter but don’t affect Strattera prescriptions.

Texas

• Telehealth for Strattera: Allowed with no restrictions
• In-person requirement: None
• Provider types: NPs/PAs can prescribe non-controlled medications with physician delegation

Texas is generally telehealth-friendly, especially for mental health care. There are no special requirements for Strattera prescriptions via telehealth.

Alabama

• Telehealth for Strattera: Allowed
• In-person requirement: Periodic (12-month) in-person visit required for ongoing telehealth care, but mental health services are exempt from this rule
• Provider considerations: Collaborative practice required for NPs

While Alabama has some of the strictest telehealth rules in the country, their mental health exemptions typically make Strattera prescribing via telehealth straightforward.

Other States

Most other states follow similar patterns, allowing telehealth prescribing of Strattera without special restrictions. Some states may have specific rules about establishing the provider-patient relationship, but these generally can be met through a comprehensive video evaluation.

Who Can Prescribe Strattera via Telehealth?

The types of providers who can prescribe Strattera through telehealth varies by state:

Physicians (MD/DO)

In all 50 states, licensed physicians can prescribe Strattera via telehealth as long as they’re licensed in the patient’s state and follow standard of care requirements.

Nurse Practitioners (NPs)

• Full authority states: In states with ‘full practice authority’ like New York, California (after meeting experience requirements), and New Hampshire, NPs can independently prescribe Strattera via telehealth
• Collaborative states: In states like Florida, Texas, Alabama, and Georgia, NPs need a collaborative agreement with a physician, but can still prescribe Strattera through telehealth

Physician Assistants (PAs)

PAs generally require supervision or collaboration with a physician in most states, but with appropriate agreements in place, they can prescribe Strattera via telehealth.

At Klarity Health, we ensure all our providers are appropriately licensed and authorized to prescribe in your state, taking the guesswork out of navigating these regulations.

What to Expect During Telehealth ADHD Evaluation

A legitimate telehealth evaluation for ADHD should be comprehensive, regardless of whether you’re seeking Strattera or other medications. Here’s what to expect:

1. Thorough assessment: Expect a detailed evaluation that follows DSM-5 criteria for ADHD diagnosis, including:

• Comprehensive history of symptoms
• Impact of symptoms across different settings (work, home, school)
• Age of symptom onset
• Review of other potential causes

1. Documentation: You may be asked to:

• Complete standardized ADHD rating scales
• Provide previous medical records if available
• Share school or work evaluations that document attention issues

1. Medical screening: The provider will:

• Review your full medical history
• Check for conditions that might contraindicate Strattera (such as narrow-angle glaucoma)
• Screen for cardiovascular issues that require monitoring

1. Treatment discussion: If ADHD is diagnosed, your provider will discuss:

• Medication options, including Strattera’s

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment